MV100052: Tris-GalNAc-PEG5-NHS Ester label-new 2-(9H-Carbazol-4-yloxy)-1-[[[2-(2-methoxyphenoxy)ethyl]amino]methyl]ethyl β-D-Glucopyranosiduronic Acid

2-(9H-Carbazol-4-yloxy)-1-[[[2-(2-methoxyphenoxy)ethyl]amino]methyl]ethyl β-D-Glucopyranosiduronic Acid

C46H74N10O21 / 1103

C14H26N4O8 / 378

C20H18D6N2O3S

2-Azidoethyl β-D-lactopyranoside

MV100052: Tris-GalNAc-PEG5-NHS Ester label-new 2-(9H-Carbazol-4-yloxy)-1-[[[2-(2-methoxyphenoxy)ethyl]amino]methyl]ethyl β-D-Glucopyranosiduronic AcidC79H137N11O37 1832. 98 A triantennary N acetylgalactosamine (Tri GalNAc) ligand presenting three GalNAc residues on a tris based branched scaffold, equipped with an N hydroxysuccinimide (NHS) activated ester through a discrete, monodisperse pentaethylene glycol (PEG5) spacer. The NHS ester reacts with primary amines to form stable amide bonds, providing a single step route to conjugate the Tri GalNAc ligand onto amine bearing payloads, antibodies,